Zhen Su, MD, MBA, is the Chief Medical Officer for North America. In his role, Dr. Su is responsible for working with the local and global medical, development and regulatory teams to lead EMD Serono’s medical strategy, clinical presence, scientific leadership in the US.
A physician executive with more than 20 years of experience, Dr. Su held roles at a number of academic institutions – including at Duke University and University of Florida, where he led early clinical development in Immuno-Oncology as a faculty member – before joining the biopharmaceutical industry. Within EMD Serono, he most recently held the position of Global Head of Medical Affairs, Oncology, prior to which, he held leadership roles in general management, clinical development and medical affairs at Sanofi and GlaxoSmithKline.
Dr. Su earned his MD degree from the Technical University of Dresden, Germany and completed his MBA training at the University of Toronto, Canada.